Inventor
CAILLE SEBASTIEN
US14 patents
Patents
14 patentsUS11465969B2Oct 11, 2022
Salts and crystal forms of omecamtiv mecarbil
AMGEN INC16 citations90
US11040956B2Jun 22, 2021
Synthesis of omecamtiv mecarbil
AMGEN INC23 citations90
US11926592B2Mar 12, 2024
Salts and crystal forms of omecamtiv mecarbil
AMGEN INC8 citations82
US9623018B2Apr 18, 2017
Processes of making and crystalline forms of a MDM2 inhibitor
AMGEN INC6 citations82
US11753394B2Sep 12, 2023
Synthesis of omecamtiv mecarbil
AMGEN INC9 citations81
US9376386B2Jun 28, 2016
Processes of making and crystalline forms of a MDM2 inhibitor
AMGEN INC7 citations80
US11702380B2Jul 18, 2023
Synthesis of omecamtiv mecarbil
AMGEN INC13 citations78
US12269811B2Apr 8, 2025
Synthesis of omecamtiv mecarbil
AMGEN INC1 citations70
US9801867B2Oct 31, 2017
Processes of making and crystalline forms of a MDM2 inhibitor
AMGEN INC2 citations69
US12526728B2Jan 13, 2026
Processes for preparing a MDM2 inhibitor
AMGEN INC0 citations60
US11753386B2Sep 12, 2023
Processes for preparing a MDM2 inhibitor
AMGEN INC0 citations60
US9757367B2Sep 12, 2017
Calcium propane-2-sulfinate dihydrate
AMGEN INC1 citations59
US9855259B2Jan 2, 2018
Processes of making and crystalline forms of a MDM2 inhibitor
AMGEN INC1 citations58
US12473281B2Nov 18, 2025
Synthesis of KRAS G12C inhibitor compound
AMGEN INC1 citations54